Bupivacaine sustained-release - MedinCell
Latest Information Update: 12 Aug 2016
At a glance
- Originator MedinCell S.A.
- Class Anilides; Local anaesthetics; Non-opioid analgesics; Pipecolic acids; Small molecules
- Mechanism of Action Sodium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Postoperative pain
Most Recent Events
- 12 Aug 2016 Chemical structure information added